Press room

IDDI in the Media.

Read the articles related to our know-how and expertise in clinical research and how we optimize the design and conduct of clinical trials.

Surrogate endpoints create potential, require statistical validation

Press room

Transforming statistical data into a surrogate endpoint can enable comprehension of trial results sooner than usual, but few make the cut after formal validation, says drug development expert and DIA panelist. READ ARTICLE HERE Interview of Dr. Marc Buyse, ScD, […]

Read more

Using disease free survival as a primary endpoint in early breast cancer

Press room

IDDI in collaboration with Roche have identified why using disease-free survival as a primary endpoint in early breast cancer is the way forward IDDI’s findings suggest that it is appropriate to use disease-free survival (DFS) as a surrogate for overall […]

Read more

IDDI: coup de pouce à la médecine personnalisée

Press

IDDI: coup de pouce à la médecine personnalisée L’entreprise de Louvain-la-Neuve développe une méthode statistique innovante, qui pourrait bousculer les essais cliniques. CHRISTOPHE DE CAEVEL Trends Tendances P20 Feb.21, 2019 Vous trouvez que les projets de recherche conduisent trop rarement […]

Read more

Personalized Medicine: Getting More Out of Clinical Trials

February 15, 2019

Press

IDDI in Contract Pharma Magazine IDDI, BMS Consortium aims to establish that the GPC statistical method can complement the design, analysis and interpretation of clinical trial results; Kristin Brooks, Contract Pharma 02.15.19 Results of randomized clinical trials can be somewhat limited. […]

Read more

IDDI, Fleuron Statistique pour les Biotechs Wallonnes

Press
Press room

IDDI, dont l’expertise dans la gestion et l’analyse des données cliniques des patients est mondialement reconnue, fait évoluer son actionnariat pour pérenniser sa structure et poursuivre son développement en Europe et aux Etats-Unis. La Société Régionale d’Investissement de Wallonie (SRIW) […]

Read more